Precision Biosciences (DTIL) Treasury Shares (2018 - 2026)
Precision Biosciences (DTIL) reported Treasury Shares of $952000.0 for Q1 2026, little changed year-over-year from $952000.0 in Q1 2025, and little changed quarter-over-quarter from $952000.0 in Q4 2025.
Precision Biosciences (DTIL) Treasury Shares (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Treasury Shares data on file, last reported at $952000.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $952000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $952000.0 (changed 0.0% YoY), and the FY2025 annual result was $952000.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $952000.0 in Q1 2026 per DTIL's latest filing, from $952000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.6 million in Q3 2025 and troughed at $214857.0 in Q4 2023.
- A 4-year average of $1.1 million and a median of $1.2 million in 2025 frame the typical range for Treasury Shares.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
- A 5-year view of Treasury Shares shows it stood at $952000.0 in 2022, then changed by 0.0% to $952000.0 in 2023, then changed by 0.0% to $952000.0 in 2024, then changed by 0.0% to $952000.0 in 2025, then changed by 0.0% to $952000.0 in 2026.
- Business Quant data shows DTIL's Treasury Shares at $952000.0 in Q1 2026, $952000.0 in Q4 2025, and $952000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 952,000.00 |
| Mar 31, 2026 | 952,000.00 |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2025 | 952,000.00 |
| Dec 31, 2025 | 952,000.00 |
| Sep 30, 2025 | 952,000.00 |
| Sep 30, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Sep 30, 2025 | 952,000.00 |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 952,000.00 |
| Jun 30, 2025 | 952,000.00 |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 952,000.00 |
| Mar 31, 2025 | 952,000.00 |
| Dec 31, 2024 | 952,000.00 |
| Dec 31, 2024 | 975,520.00 |